Radio and PodcastRadio and PodcastLive Radio & Podcasts
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates artwork
Science & Medicine

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Lung Cancer Update by Dr. Neil Love

Aug 18, 202517:44Science & Medicine

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and s...

Related Episodes

Continue listening to more episodes from Lung Cancer Update.